Breaking Finance News

ResMed Inc. (NYSE:RMD) has been upgraded to Buy in a statement by Bank of America Corp. earlier today.

Having a price of $64.49, ResMed Inc. (NYSE:RMD) traded 0.25% higher on the day. With the last stock price up 4.03% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. RMD has recorded a 50-day average of $67.05 and a two hundred day average of $62.16. Trade Volume was down over the average, with 336,479 shares of RMD changing hands under the typical 959,227

Bank of America Corp. has upgraded ResMed Inc. (NYSE:RMD) to Buy in a statement released on Thursday September 29, 2016.

See Chart Below

ResMed Inc. (NYSE:RMD)

ResMed Inc. has a 52 week low of $50.47 and a 52 week high of $70.90 with a P/E ratio of 25.97 The company’s market cap is currently $0.

In addition to Bank of America Corp. reporting its target price, a total of 11 firms have issued a report on the stock. The consensus target price is $59.06 with 1 firm rating the stock a strong buy, 4 firms rating the stock a buy, 8 firms rating the stock a hold, 2 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.

About ResMed Inc. (NYSE:RMD)

ResMed Inc. is a holding company. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. The Company develops a range of products for sleep-disordered breathing and other respiratory disorders, including airdevices, informatics solutions, diagnostic products, mask systems, headgear and other accessories. The Company owns interest in Inova Labs Inc., a medical device company specializing in the development and commercialization of oxygen therapy products. The Company holds interest in Brightree LLC, a provider of business management and clinical software applications for the post-acute care industry. The Company's manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.